Clinical Trials Browser

Recruiting × INDUSTRY × Immune Checkpoint Inhibitors × Clear all

NCT06819735 2026-05-06

DOMISOL

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06190275 2026-04-24

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

Phase NA Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07171606 2025-12-18

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Phase 2 Recruiting

First-line Advanced NSCLC Patients

NCT06063681 2025-06-08

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Phase 1 Recruiting

Neoplasm Metastasis, Recurrence

NCT04673942 2024-10-26

BETA-PRIME

Phase 2 Recruiting

Adenoviridae Infections, Chondrosarcoma, Neoplasms, Sarcoma

NCT05037825 2022-04-27

PARADIGM

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms